OphSourceHomeJournal CollectionOphSource ShopEvents
Journal Home
Search for

Volume 110, Issue 4, Pages 743-747 (April 2003)


View previous. 34 of 52 View next.

Infectious keratitis after photorefractive keratectomy

Eric D Donnenfeld, MDCorresponding Author Information12, Terrence P O’Brien, MD3, Renée Solomon, MD2, Henry D Perry, MD12, Mark G Speaker, MD4, John Wittpenn, MD12

Received 15 February 2002; accepted 7 December 2002.

Abstract 

Purpose

To elucidate risk factors, microbial culture results, and visual outcomes for infectious keratitis after photorefractive keratectomy (PRK).

Design

Multicenter, retrospective chart review, case report, and literature review.

Methods

The records of 12 patients with infectious keratitis after PRK were reviewed.

Main outcome measures

Causative organism, response to medical treatment, and visual outcome.

Results

Infectious keratitis developed in 13 eyes of 12 patients after PRK. Organisms cultured were Staphylococcus aureus (n = 5), including a bilateral case of methicillin-resistant Staphylococcus aureus; Staphylococcus epidermidis (n = 4); Streptococcus pneumoniae (n = 3); and Streptococcus viridans (n = 1). Four patients manipulated their contact lenses, and 2 patients were exposed to nosocomial organisms while working in a hospital environment. Prophylactic antibiotics used were tobramycin (nine cases), polymyxin B-trimethoprim (three cases), and ciprofloxacin (one case). Final best spectacle-corrected visual acuity ranged from 20/20 to 20/100.

Conclusions

Infectious corneal ulceration is a serious potential complication of PRK. Gram-positive organisms are the most common pathogens. Antibiotic prophylaxis should be broad spectrum and should include gram-positive coverage.

1 Department of Ophthalmology, Nassau University Medical Center, East Meadow, New York, USA

2 Ophthalmic Consultants of Long Island, Rockville Centre, New York, USA

3 Department of Ophthalmology, The Wilmer Eye Institute, The Johns Hopkins Hospital, Baltimore, Maryland, USA

4 Department of Ophthalmology, New York Eye and Ear Infirmary, New York, New York, USA

Corresponding Author InformationCorrespondence and reprint requests to Eric D. Donnenfeld, MD, Ophthalmic Consultants of Long Island, Ryan Medical Arts Building, Suite 402, 2000 North Village Avenue, Rockville Centre, NY 11570, USA.

 Manuscript no. 220109

Supported in part by the Lions Eye Bank of Long Island, New York.

PII: S0161-6420(02)01936-X

doi:10.1016/S0161-6420(02)01936-X


View previous. 34 of 52 View next.